The data for GP3 and SCCA-1 in this group of ALD/NAFLD patients with and without HCC is also presented in Figures 1 and 2 and Table 2 and 3. This evidence concerns the gene SERPINB3 and metabolic dysfunction-associated steatotic liver disease.